table of content
1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview
1.1 Product Overview and Scope of Chemotherapy-Induced Nausea and Vomiting Drugs
1.2 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Type
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Existing Drugs
1.2.3 Akynzeo (Netupitant-Palonosetron FDC)
1.2.4 Aloxi (Palonosetron)
1.2.5 Emend (Aprepitant)
1.2.6 Kytril Generic (Granisetron)
1.2.7 Zofran Generic (Ondansetron)
1.2.8 Pipeline Drugs
1.2.9 SUSTOL (Granisetron Injection extended release)
1.2.10 Rolapitant
1.3 Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Application
1.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Serotonin Receptor Antagonists
1.3.3 NK1 Receptor Antagonists
1.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Estimates and Forecasts
1.4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue 2017-2028
1.4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales 2017-2028
1.4.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Competition by Manufacturers
2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Sites, Area Served, Product Type
2.5 Chemotherapy-Induced Nausea and Vomiting Drugs Market Competitive Situation and Trends
2.5.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Chemotherapy-Induced Nausea and Vomiting Drugs Players Market Share by Revenue
2.5.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chemotherapy-Induced Nausea and Vomiting Drugs Retrospective Market Scenario by Region
3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.3.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country
3.3.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.4.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country
3.4.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Region
3.5.2 Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.6.1 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country
3.6.2 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Country
3.7.2 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historic Market Analysis by Type
4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type (2017-2022)
4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2017-2022)
5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historic Market Analysis by Application
5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2017-2022)
5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Merck & Co., Inc.
6.1.1 Merck & Co., Inc. Corporation Information
6.1.2 Merck & Co., Inc. Description and Business Overview
6.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.1.5 Merck & Co., Inc. Recent Developments/Updates
6.2 GlaxoSmithKline plc
6.2.1 GlaxoSmithKline plc Corporation Information
6.2.2 GlaxoSmithKline plc Description and Business Overview
6.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.2.5 GlaxoSmithKline plc Recent Developments/Updates
6.3 Tesaro, Inc.
6.3.1 Tesaro, Inc. Corporation Information
6.3.2 Tesaro, Inc. Description and Business Overview
6.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.3.5 Tesaro, Inc. Recent Developments/Updates
6.4 Helsinn Group
6.4.1 Helsinn Group Corporation Information
6.4.2 Helsinn Group Description and Business Overview
6.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.4.5 Helsinn Group Recent Developments/Updates
6.5 F. Hoffmann-La Roche Ltd.
6.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.5.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.5.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.6 Heron Therapeutics, Inc.
6.6.1 Heron Therapeutics, Inc. Corporation Information
6.6.2 Heron Therapeutics, Inc. Description and Business Overview
6.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.6.5 Heron Therapeutics, Inc. Recent Developments/Updates
6.7 Dr. Reddy's Laboratories Ltd.
6.6.1 Dr. Reddy's Laboratories Ltd. Corporation Information
6.6.2 Dr. Reddy's Laboratories Ltd. Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.7.5 Dr. Reddy's Laboratories Ltd. Recent Developments/Updates
6.8 Acacia Pharma
6.8.1 Acacia Pharma Corporation Information
6.8.2 Acacia Pharma Description and Business Overview
6.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.8.5 Acacia Pharma Recent Developments/Updates
6.9 Sun Pharmaceutical Industry Ltd.
6.9.1 Sun Pharmaceutical Industry Ltd. Corporation Information
6.9.2 Sun Pharmaceutical Industry Ltd. Description and Business Overview
6.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.9.5 Sun Pharmaceutical Industry Ltd. Recent Developments/Updates
6.10 Otsuka Holdings Co., Ltd.
6.10.1 Otsuka Holdings Co., Ltd. Corporation Information
6.10.2 Otsuka Holdings Co., Ltd. Description and Business Overview
6.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Portfolio
6.10.5 Otsuka Holdings Co., Ltd. Recent Developments/Updates
7 Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Cost Analysis
7.1 Chemotherapy-Induced Nausea and Vomiting Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs
7.4 Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors List
8.3 Chemotherapy-Induced Nausea and Vomiting Drugs Customers
9 Chemotherapy-Induced Nausea and Vomiting Drugs Market Dynamics
9.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Trends
9.2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers
9.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges
9.4 Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
10 Global Market Forecast
10.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2023-2028)
10.2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Chemotherapy-Induced Nausea and Vomiting Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Chemotherapy-Induced Nausea and Vomiting Drugs by Application (2023-2028)
10.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Chemotherapy-Induced Nausea and Vomiting Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Chemotherapy-Induced Nausea and Vomiting Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
